Reducing outpatient drug-related problems through pharmacist led interventions: A multi-center interventional study in provincial hospitals in Vietnam
Main Article Content
Keywords
Drug-related problems, pharmacist intervention, outpatient prescribing, clinical pharmacy, Vietnam
Abstract
Background: Drug-related problems (DRPs) significantly affect patient safety, clinical outcomes, and healthcare efficiency. Pharmacist-led interventions have demonstrated potential in improving prescribing practices, yet limited data exist on their effectiveness in outpatient settings in Vietnam. This study evaluated the impact of structured pharmacist interventions on reducing DRPs in outpatient prescriptions at multiple healthcare facilities in a province in Vietnam. Methods: A pre-post interventional study was conducted at three hospitals in a province in Vietnam. Pharmacists systematically reviewed outpatient prescriptions identified DRPs using version v9.1 of the Pharmaceutical Care Network Europe (PCNE) classification and selected criteria from Vietnam’s Ministry of Health classification, and provided structured interventions, including quarterly seminars, hospital DRP bulletins, and personalized physician-specific DRP information sheets. Multivariate logistic regression assessed factors associated with DRP. Results: In total, 4,070 prescriptions preintervention and 4,051 prescriptions post-intervention were analyzed. Pharmacist-led interventions significantly reduced the proportion of prescriptions with at least one DRP from 21.7% (pre-intervention) to 9.1% (post-intervention; p<0.001). Significant reductions were observed across multiple DRP categories, including inappropriate drug indications, contraindicated medications, unnecessary drug prescriptions, incorrect dosing, improper timing of administration, and clinically significant drug-drug interactions (p<0.001). Factors independently associated with higher DRP risk included patient age ≥60 years (OR=1.554; p<0.001) and prescriptions containing five or more medications (OR=2.435; p<0.001). Proton pump inhibitors, gastrointestinal motility regulators, and non-steroidal anti-inflammatory drugs (NSAIDs) were most frequently implicated in DRPs. Conclusions: Pharmacist-led interventions effectively reduced DRPs in outpatient prescriptions at provincial hospitals in Vietnam. Older patients and those receiving polypharmacy were at higher risk, highlighting the need for targeted pharmaceutical care. This intervention model is practical, scalable, and well-suited for integration into electronic prescribing systems, significantly enhancing medication safety and prescribing quality.
References
2. Al-Azzam S, Alzoubi K, Aburuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan. Ther Clin Risk Manag. 2016;12:233-239.
3. Kaufmann CP, Stampfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376.
4. Qassemi S, Pagès A, Rouch L, Bismuth S, Stillmunkes A, Lapeyre-Mestre M, McCambridge C, Cool C, Cestac P. Potentially inappropriate drug prescribing in French nursing home residents: an observational study. Pharmacy. 2020;8(3):133.
5. Nguyen KT, Le VTT, Nguyen TH, Pham ST, Nguyen PM, Taxis K, Vi MT, Nguyen T, Tran HD. Effect of pharmacist-led interventions on physicians’ prescribing for pediatric outpatients. Healthcare. 2022;10(4):751.
6. Sagita VA, Bahtiar A, Andrajati R. Evaluation of a clinical pharmacist intervention on clinical and drug-related problems among coronary heart disease inpatients: a pre-experimental prospective study at a general hospital in Indonesia. Sultan Qaboos Univ Med J. 2018;18(1):e82-e87.
7. Vietnam Ministry of Health. Decision No. 4041/QĐ-BYT on the approval of the proposal to strengthen the control of prescription and prescription drug sales for the period 2017–2020. Hanoi: Ministry of Health; 2017.
8. Nguyen NA, Nguyen T, Pham ST, Nguyen TH. Pharmacist-led interventions to reduce drug-related problems in prescribing for Vietnamese outpatients. Pharm Sci Asia. 2022;49(1):106-113.
9. Nguyen HT, Bero L. A systematic review of drug-related problems in Vietnam: prevalence, causes and interventions. J Clin Pharm Ther. 2021;46(4):918-928.
10. Vo TH, Bedouch P, Nguyen TH, et al. Pharmacy practice in Vietnam: current situation, challenges, and future perspectives. Res Social Adm Pharm. 2020;16(10):1352-1358.
11. Allen B, Williams M, Peterson GM. Pharmacist-led medication reviews to identify and collaboratively resolve drug-related problems in psychiatry – a controlled clinical trial. PLoS One. 2016;10(11):e0142011.
12. Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658-1665.
13. Mekonnen AB, McLachlan AJ, Brien JE. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016;6(2):e010003.
14. Liao Y, Ma C, Zhu H, et al. Impact of pharmacist intervention on the prescription of potentially inappropriate medication in elderly patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2021;77(2):271-282.
15. Ayhan YE, Aksoy M, Abdulrahman Y, Şahin Eröksüz ZS, Vezir D, Mercümek B, Bektay MY, Karakurt S, Sancar M. Evaluation of the effect of management of drug-related problems on clinical outcomes of pulmonary embolism outpatients: A randomized controlled trial. J Clin Med. 2025;14(4):1202.
16. Tantipinichwong N, Keller MS. Operation Polypharmacy: a pharmacist-led ambulatory care clinic design and evaluation for older patients. Sci Rep. 2024;14:31719.
17. Al-Taani GM, Muflih SM, Al-Azzam SI, Alzoubi KH. Costs saved and avoided from pharmacist interventions to address drug-related problems identified in outpatient clinics in Jordan. PLoS One. 2024;19(6):e0302287.
18. Riley K, Yap K, Foley G, Lambe J, Lund S. Impact of a clinical decision support system on identifying drug-related problems and making recommendations to providers during community pharmacist-led medication reviews in Ontario, Canada: A pilot study. J Eval Clin Pract. 2025;31(2):e14123.
19. Ensing HT, Kurt N, Janssen RA, Koster ES, Heerdink ER. Pharmacist-led New Medicine Service: a real-world cohort study in the Netherlands on drug-related problems, satisfaction, and self-efficacy in cardiovascular patients transitioning to primary care. Int J Clin Pharm. 2025;47:325-334.
20. Albabtain B, Bawazeer G, Paudyal V, Cheema E, Alqahtani A, Bahatheq A, Price MJ, Hadi MA. Impact of a community pharmacy-based medication therapy management program on clinical and humanistic outcomes in patients with uncontrolled diabetes: A randomised controlled trial. Sci Rep. 2024;14:17818.
21. Fentie AM, Huluka SA, Gebremariam GT, Gebretekle GB, Abebe E, Fenta TG. Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: A systematic review and meta-analysis of randomized control trials. Res Social Adm Pharm. 2024;20(5):487-497.
22. Qassemi S, Rouch L, Bismuth S, Stillmunkes A, Lapeyre-Mestre M, McCambridge C, Cestac P. Potentially inappropriate drug prescribing in French nursing home residents: an observational study. Pharmacy (Basel). 2020;8(3):133.
23. Kusumawardani LA, Andrajati R, Nusaibah A. Drug-related problems in hypertensive patients: A cross-sectional study from Indonesia. J Res Pharm Pract. 2020;9(3):140.
24. Vietnam Ministry of Health. Decision No. 749/QĐ-TTg. National Digital Transformation Program until 2025, orientation towards 2030. Hanoi: Ministry of Health; 2020.
25. Communist Party of Vietnam. Resolution No. 52-NQ/TW. Guidelines and policies for active participation in the Fourth Industrial Revolution. Hanoi: Central Committee of the Communist Party; 2019.
26. Prime Minister of Vietnam. Decision No. 376/QĐ-BYT. Implementation plan for digital transformation in the health sector until 2025. Hanoi: Government Office; 2021.
27. Hoang HT, Nguyen BT, Dang TT, et al. Leveraging digital health for clinical pharmacy development in Vietnam: current status and future directions. Pharm Pract. 2022;20(4):2774.
28. Le VH, Tran TTH, Pham TP, et al. Digital transformation in Vietnamese healthcare: opportunities and challenges for clinical pharmacy services integration. Digit Health. 2023;9:20552076231168034.
